Zobrazeno 1 - 2
of 2
pro vyhledávání: '"CHC, chronic HCV"'
Autor:
Charlotte E. Costentin, P. Nahon
Publikováno v:
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (4), pp.100320. ⟨10.1016/j.jhepr.2021.100320⟩
JHEP Reports
JHEP Reports Innovation in Hepatology, 2021, 3 (4), pp.100320. ⟨10.1016/j.jhepr.2021.100320⟩
JHEP Reports, Vol 3, Iss 4, Pp 100320-(2021)
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (4), pp.100320. ⟨10.1016/j.jhepr.2021.100320⟩
JHEP Reports
JHEP Reports Innovation in Hepatology, 2021, 3 (4), pp.100320. ⟨10.1016/j.jhepr.2021.100320⟩
JHEP Reports, Vol 3, Iss 4, Pp 100320-(2021)
Background & Aims The Liver Cancer Risk test algorithm (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein-A1 and haptoglobin), known hepatocellular carcinoma (HCC) risk factors (sex, age, and gam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b9625ae9e7df7bbcecf40723b8ab975
https://hal.sorbonne-universite.fr/hal-03334459
https://hal.sorbonne-universite.fr/hal-03334459
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
Autor:
Poynard T; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France., Lacombe JM; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France., Deckmyn O; BioPredictive, Paris, France., Peta V; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.; BioPredictive, Paris, France., Akhavan S; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France., de Ledinghen V; Hepatology Unit Hôpital Haut-Lévêque, Pessac, and INSERM U1053, Université Bordeaux Segalen, Bordeaux, France., Zoulim F; Hospices civils de Lyon, Hôpital Croix Rousse, Department of Hepatology, INSERM U1052, Université de Lyon, Lyon, France., Samuel D; AP-HP, Hospital Paul Brousse, Hepatology Department, UMR-S1193, Villejuif, France.; Université Paris-Saclay, and Hepatinov, Villejuif, France., Mathurin P; CHRU Claude Huriez, Hepatology Department Lille, France., Ratziu V; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France., Thabut D; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France., Housset C; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France., Fontaine H; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, AP-HP, Hôpital Cochin, Hepatology Department, Paris, France., Pol S; Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Hepato-Gastroenterology, AP-HP, Hôpital Cochin, Hepatology Department, Paris, France., Carrat F; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Apr 24; Vol. 3 (4), pp. 100298. Date of Electronic Publication: 2021 Apr 24 (Print Publication: 2021).
